CSBR:NASDAQ
Champions Oncology Inc
4,70 USD
0,00%
(0,00) 1 D
13. nov., 15:57:39 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Markedsverdi
65,49 mill.
Snittvolum
8,15k
Volum
190,00
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Markedsverdi
65,49 mill.
Snittvolum
8,15k
Volum
190,00
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
upi
·
for 1 time siden
KB Kookmin Bank debuts S&P 500-linked dollar deposit product
Benzinga
·
for 14 minutter siden
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
Coinpaper
·
for 1 time siden
Stock Market Today: S&P 500 and Nasdaq Fall as Nvidia Selloff Deepens
Traders Union
·
for 39 minutter siden
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com